Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Indomethacin Versus Diclofenac for Prevention of Post-ERCP Panceratitis (IDPPP2): A Multicenter, Double-blind, Randomized, Control Trial

NCT07071441 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT07071441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07071441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Indomethacin Versus Diclofenac for Prevention of Post-ERCP Panceratitis (IDPPP2): A Multicenter, Double-blind, Randomized, Control Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 31, 2026
Enrollment
4,050 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

diclofenac, ercp, indomethacin, non-steroidal anti-inflammatory (nsaid), pancreatitis